Overview

The use and abuse of drugs, and their effects on behavior The book integrates information from the various fields, including pharmacology, neuroscience, psychology and psychiatry, to provide a broad perspective on how drugs affect behavioral processes. Drugs, Brain and Behavior describes the psychological effects of drugs, and how drug actions can be understood in terms of effects on the brain. This discussion includes drugs that are used for the treatment of psychiatric disorders, as well as common drugs of abuse. Rather than simply focusing on drug dependence and addiction, this text also places considerable emphasis on drug treatments for various psychiatric disorders such as: schizophrenia, depression, anxiety, parkinsonism, ADHD and Alzheimer’s disease. It also combines neurotransmitter-based approaches to the field with perspectives that emphasize specific drugs and distinct drug categories. Intended for Undergraduate courses in Psychopharmacology and/or Drugs and Behavior, this new edition of Drugs, Brain, and Behavior provides an overview of the field of psychopharmacology, which focuses on the behavioral effects of drugs. Teaching & Learning Experience Personalize Learning — The new MySearchLab with eText delivers proven results in helping students succeed and provides engaging experiences that personalize learning. Improve Critical Thinking — Content encourages students to consider the psychological effects of drugs and how drug actions can be understood in terms of effects on the brain. Engage Students — Updated references and figures reflect current trends and data. Explore Research — Discussions of pharmacotherapy in psychiatry, current neurochemical hypotheses, and general phenomena of drug dependence and use, among other topics. Support Instructors - MyTest, PowerPoints, and an instructor’s manual offer additional support for instructors.

Full Product Details

Author:   David M. Grilly ,  John Salamone
Publisher:   Pearson Education (US)
Imprint:   Pearson
Edition:   6th edition
Dimensions:   Width: 18.70cm , Height: 2.50cm , Length: 23.20cm
Weight:   0.630kg
ISBN:  

9780205750528

ISBN 10:   0205750524
Pages:   464
Publication Date:   20 October 2011
Audience:   Professional and scholarly ,  College/higher education ,  Professional & Vocational ,  Tertiary & Higher Education
Replaced By:   9780205230372
Format:   Paperback
Publisher's Status:   Out of Print
Availability:   Out of stock  

Table of Contents

IN THIS SECTION: 1.) BRIEF 2.) COMPREHENSIVE BRIEF TABLE OF CONTENTS: Chapter 1: Psychopharmacology in Perspective Chapter 2: Drug Classification and Behavioral Assessment Chapter 3: Basic Principles of Pharmacology Chapter 4: Excitability and Chemical Properties of Nerve Cells Chapter 5: Synaptic Transmission, Drugs, & Chemical Neuroanatomy Chapter 6: Tolerance, Sensitization, Dependence & Addiction Chapter 7: Psychomotor Stimulants & Antiparkinsonian Drugs Chapter 8: Antipsychotic Drugs & Neurochemical Hypotheses of Schizophrenia Chapter 9: Antidepressants & Mood Stabilizers Chapter 10: Sedative-Hypnotics, Anxiolytics and Anticonvulsants Chapter 11: Drug Treatment of Cognitive Dysfunction Chapter 12: Naturally Occurring & Synthetic Opiates & their Antagonists Chapter 13: Dissociative Anesthetics, Psychedelics, & Hallucinogens COMPREHENSIVE TABLE OF CONTENTS: Chapter 1: Psychopharmacology in Perspective A Historical Overview of Psychopharmacology Predecessors to Modern Pharmacotherapies The Psychopharmacological Revolution Recreational and Social Drug Use Summary and Overview Chapter 2: Drug Classification and Behavioral Assessment Drug Classifications Based upon Behavioral or Therapeutic Actions Drug Classification Based upon Basic Neurochemical Actions Drug Names and Medical Uses of Drugs Schedule-Controlled Drugs Chapter 3: Basic Principles of Pharmacology Basic Chemical Principles Related to Psychopharmacology Routes of Administration Importance of the Blood-Brain Barrier in Psychopharmacology Dose—Response Relationships Drug Metabolism and Excretion Implications of Pharmacokinetics in the Fetus and Neonate Pharmacogenetic and Ethnic Factors in Drug Action Chapter 4: Excitability and Chemical Properties of Nerve Cells The Neuron Electrical Excitability of Neurons: The Resting Membrane Potential Electrical Excitability of Neurons: Excitation, Inhibition, and the Action Potential Integration, Computation and Chemical Signaling in Neurons Additional Features of Chemical Neurotransmission Chapter 5: Synaptic Transmission, Drugs, & Chemical Neuroanatomy Neurotransmitters & Chemical Signaling in the Nervous System Synthesis of Neurotransmitters Storage of Neurotransmitters Release of Neurotransmitters Postsynaptic Actions of Neurotransmitters Inactivation of Neurotransmitters Chemical Neuroanatomy & Neurotransmitter Distribution Chapter 6: Tolerance, Sensitization, Dependence & Addiction Tolerance& Sensitization Tolerance & Sensitization Mechanisms Dependence, Abuse & Addiction General Factors in Treatment for Drug Dependency State-Dependent Learning Chapter 7: Psychomotor Stimulants & Antiparkinsonian Drugs Motor Effects of Psychomotor Stimulants Caffeine Nicotine Amphetamines and Related Drugs Cocaine Treatment of Cocaine and Amphetamine Abuse Modafinil Parkinson’s Disease Chapter 8: Antipsychotic Drugs & Neurochemical Hypotheses of Schizophrenia Symptoms of Schizophrenia Discovery and Characterization of Antipsychotic Drugs Neurochemical and Neuropathological Hypotheses of Schizophrenia Current Pharmacotherapy for Schizophrenia Chapter 9: Antidepressants & Mood Stabilizers Pharmacotherapy for Depression Neurobiological Hypotheses of Affective Disorders Nondrug Treatments for Depression Placebo Effects and Antidepressant Actions Pharmacotherapy in Mania and Bipolar Illnesses Chapter 10: Sedative-Hypnotics, Anxiolytics and Anticonvulsants Alcohol (Ethanol) Barbiturates and Other Sedative—Hypnotics Inhalants: Anesthetic Gases and Solvents Anxiolytics Sedative—Hypnotics and Insomnia Drug Treatment of Epilepsy: Anticonvulsant Drugs Chapter 11: Drug Treatment of Cognitive Dysfunction Attention Deficit Hyperactivity Disorder Psychomotor Stimulants, Learning, & Memory Treatment of Alzheimer’s Disease & Senile Dementia Chapter 12: Naturally Occurring & Synthetic Opiates & their Antagonists Endogenous Opioid Peptides and Their Receptors Typical Opiates The “Overdose” Phenomenon Legal Factors in the Narcotics Problem Opiate Antagonists: Potential Uses Chapter 13: Dissociative Anesthetics, Psychedelics, & Hallucinogens Some General Characteristics of P/P/Hs Monoamine-Related P/P/Hs Cannabinoids Dissociative Anesthetics: Phencyclidine and Ketamine Dissociative Anesthetics, Psychedelics & Hallucinogens: The Human Experience

Reviews

Author Information

Author #1: After earning his doctorate in experimental psychology at the University of New Mexico in 1971, Dr. Grilly spent the next two years investigating the behavioral effects of cannabinoids after acute and chronic exposure in chimpanzees at Holloman Air Force Base in Alamogordo, New Mexico.  He then moved to Cleveland, Ohio, to take a position as a faculty member in the Psychology Department at Cleveland State University, where he spent the remainder of his 38 year career.  His research at CSU, primarily with rats, involved investigations of a variety of psychoactive drugs on a variety of behaviors.  These included investigating the potential use of signal detection theory in assessing  nociception and opiate withdrawal, determining the effects of drugs  on attentional processes (e.g., naltrexone, diprenorphine, morphine, barbiturates, amphetamine, cocaine, fluoxetine, nicotine, pemoline) and conditioned avoidance/escape behavior (e.g., clonidine, chlorpromazine, morphine), determining whether the effects of psychostimulants (e.g., cocaine, amphetamine) on sustained attention change with aging, and comparing the effects of very low to very high doses of amphetamine in rats with those shown in humans.  He also conducted research with humans investigating the effect of marijuana on visual short term memory and the changes in people’s perceptions of the effects of marijuana on driving.    Author #2: Dr. John Salamone received his bachelor's degree from Rockhurst University in Kansas City, Missouri in 1978. He was a psychology major and biology minor.  Dr. Salamone then entered the psychobiology program at Emory University in Atlanta, Georgia, and graduated with a Ph.D. in 1982.  For postdoctoral training, Dr. Salamone received a National Science Foundation grant, and studied at Cambridge University in England. Dr. Salamone stayed in England for several more years, working at Merck, Sharpe and Dohme pharmaceutical laboratories. Upon returning to the United States, Dr. Salamone joined the Behavioral Neuroscience department at the University of Pittsburgh in 1986, and joined the Psychology Department at UConn in the fall of 1988. Dr. Salamone is now a Board of Trustees Distinguished Professor; he also is the chair of the Interdisciplinary Program in Neuroscience, and the head of the Behavioral Neuroscience Division of the Psychology Department. Dr. Salamone's research is largely in the fields of behavioral neuroscience and psychopharmacology, with an emphasis on studies related to Parkinson’s disease, depression, motivation, and effort-related decision making. Dr. Salamone has been the research advisor for more than 40 undergraduate honors students at the University of Connecticut. He was inducted as a member of the Connecticut Academy of Arts and Sciences in 2002, and he has received the University of Connecticut Alumni Association Award for Excellence in Teaching. His daughter, Isabella Salamone, is currently an honor student studying biology at the University of Pittsburgh. Dr. Salamone’s hobbies include travel, astronomy, book collecting and cooking.

Tab Content 6

Author Website:  

Countries Available

All regions